Neoadjuvant chemotherapy for advanced ovarian cancer (multiple letters)

Gynecologic Oncology

Volumn 74, Issue 2, 1999, Pages 311-312

  Eisenkop, S M ^a   Spirtos, N M ^a   Friedman, R L ^a   Schwartz, P E ^a   Chambers, J T ^a   Rutherford, T J ^a   Thiel, R P ^a  

^a Departments of Pathology   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOTOXIC AGENT; PLATINUM;

ADJUVANT CHEMOTHERAPY; ADULT; AGE; CANCER ADJUVANT THERAPY; CANCER GROWTH; CANCER MORTALITY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; HUMAN; INTERMETHOD COMPARISON; LETTER; OVARY CANCER; PRIORITY JOURNAL;

EID: 0032766262     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1999.5529     Document Type: Editorial

References (6)

1. PE Schwartz TJ Rutherford JT Chambers EI Kohorn RP Thiel Neoadjuvant chemotherapy for advanced ovarian cancer: Long-term survival Gynecol Oncol 72 1999 93 99
2. SM Eisenkop RL Friedman H Wang Complete cytoreductive surgery is feasible and mazimizes survival in patients with advanced epithelial ovarian cancer: A prospective study Gynecol Oncol 69 1998 103 106
3. NM Spirtos GM Gross JL Freddo SC Ballon Cytoreductive surgery in advanced epithelial cancer of the ovary: The impact of aortic and pelvic lymphadenectomy Gynecol Oncol 56 1995 345 352
4. T Le GV Krepart RJ Lotocki MS Heywood Does debulking surgery improve survival in biologically aggressive ovarian cancer Gynecol Oncol 67 1997 208 218
5. SM Eisenkop RH Nalick N NH Teng Modified posterior exenteration for ovarian cancer Obstet Gynecol 78 1991 879 885
6. E Brand N Pearlman Electrosurgical debulking for ovarian cancer: A new technique using the Argon Beam Coagulator Gynecol Oncol 39 1990 115 118